Kim O J, Yates J L
Department of Human Genetics, Roswell Park Cancer Institute, Buffalo, New York 14263-0001.
J Virol. 1993 Dec;67(12):7634-40. doi: 10.1128/JVI.67.12.7634-7640.1993.
We have isolated mutants of Epstein-Barr virus (EBV) which carry a dominant selectable marker inserted into the third exon of the gene encoding two membrane proteins, TP1 and TP2 (or LMP2A and LMP2B), which are expressed in latently infected, growth-transformed B cells. One of the mutants also acquired a 260-bp deletion beginning in the first intron a few base pairs from the terminal repeats and removing most of the second TP exon, including the initial coding sequences of TP2. These EBV mutants transform human B cells in culture, and the transformed B-cell clones carrying them release EBV at approximately normal frequencies.
我们已经分离出了爱泼斯坦-巴尔病毒(EBV)的突变体,这些突变体携带一个显性选择标记,该标记插入到编码两种膜蛋白TP1和TP2(或LMP2A和LMP2B)的基因的第三个外显子中,这两种蛋白在潜伏感染、生长转化的B细胞中表达。其中一个突变体还在第一个内含子中获得了一个260碱基对的缺失,该缺失从距末端重复序列几个碱基对处开始,并去除了第二个TP外显子的大部分,包括TP2的初始编码序列。这些EBV突变体在培养中转化人B细胞,携带它们的转化B细胞克隆以大致正常的频率释放EBV。